Atlas Trials

An Observational Study to Evaluate Effectiveness and Safety of Upadacitinib in Chinese Adult Participants With Moderate to Severely Active Ulcerative Colitis (UC)

Clinical trial NCT06838845 · RECRUITING

Trial details

NCT number
NCT06838845
Sponsor
AbbVie
Status
RECRUITING
Study type
OBSERVATIONAL
Ulcerative Colitis
Start date
2025-04-09
Primary completion
2026-12-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.